The Edge Singapore7d
Hyphens Pharma gains exclusive rights to commercialise autoinjector pen for rheumatoid arthritis in four Asean countries
The treatment pen, called Metroject, is already a first-line treatment for rheumatoid arthritis in Europe and America.
Singapore Business Review on MSN7d
Hyphens Pharma gets exclusive rights to distribute European autoinjector
It will distributed in Singapore, Malaysia, the Philippines, and Vietnam. Hyphens Pharma International Limited’s subsidiary, ...